Skip to main content
Clinical Trials/NCT00000255
NCT00000255
Completed
Phase 2

Differential Acute Tolerance Development to Effects of Nitrous Oxide

University of Chicago1 site in 1 country10 target enrollmentApril 1995

Overview

Phase
Phase 2
Intervention
Nitrous oxide
Conditions
Opioid-Related Disorders
Sponsor
University of Chicago
Enrollment
10
Locations
1
Primary Endpoint
Pain intensity, pain bothersomeness
Status
Completed
Last Updated
10 years ago

Overview

Brief Summary

The purpose of this study is to conduct experiments to examine subjective and reinforcing effects of nitrous oxide. Mood altering and psychomotor effects will be tested on non-drug abusers and preference procedures will be used to assess reinforcing effects. To examine differential acute tolerance development to effects of nitrous oxide in humans.

Registry
clinicaltrials.gov
Start Date
April 1995
End Date
May 1996
Last Updated
10 years ago
Study Type
Interventional
Study Design
Crossover
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Arms & Interventions

30% nitrous oxide

Intervention: Nitrous oxide

20% nitrous oxide

Intervention: Nitrous oxide

0% Nitrous oxide

Intervention: Nitrous oxide

10% nitrous oxide

Intervention: Nitrous oxide

40% nitrous oxide

Intervention: Nitrous oxide

Outcomes

Primary Outcomes

Pain intensity, pain bothersomeness

Time Frame: 25, 70, & 115 min of inhalation and 40 min post

Subjects will inhale varying conc of nitrous oxide for 120 min with cold immersion of forearm at 25, 70, and 115 min and 40 min after inhalation. Pain intensity and bothersomeness will be assessed at each immersion.

Study Sites (1)

Loading locations...

Similar Trials